AMGN R&D to Revenue

Amgen · R&D to Revenue

AMGN logo

AMGN R&D to Revenue

Latest reported18.58%
AMGN Quarterly R&D/Revenue (0.00% → 18.58%)
High-resolution chart · PNG

AMGN r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen R&D to Revenue — Quarterly
Period endingR&D to Revenue
18.5797%
19.9466%
21.7361%
19.8807%
19.0248%
18.2354%
18.9742%
17.0528%
17.2508%
18.0341%
18.7164%
15.6309%
15.9319%
17.3301%
19.3596%
16.7168%
15.7567%
15.3735%
19.6903%
21.2049%
16.5798%
16.3871%
18.5258%
16.5343%
15.5334%
15.452%
21.1715%
17.4481%
15.7384%
15.8179%
18.9727%
15.6843%
14.3423%
13.6838%
17.9766%
15.1914%
15.0258%
14.0739%
18.0721%
17.0367%
15.8228%
15.7771%
19.7435%
19.5527%
17.9516%
17.7628%
23.1476%
20.2345%
19.6525%
22.7162%
24.9252%
20.8298%
20.6668%
20.7173%
21.2169%
20.3751%
18.4499%
18.1818%
21.4196%
19.2951%
20.687%
19.8597%
22.2338%
18.8417%
17.7445%
17.9844%
23.392%
16.9727%
18.6642%
19.1354%
21.2743%
18.8129%
21.4931%
19.2084%
21.9493%
21.4899%
21.9152%
23.0811%
27.4055%
24.1417%
21.8646%
20.3606%
20.2079%
17.8186%
17.8752%
18.4963%
21.21%
18.5035%
18.1051%
18.822%
21.4337%
18.4833%
19.2886%
19.9466%
20.7803%
20.8497%
19.9812%
20.1686%
20.6884%
21.623%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.